22nd Century Research and Development Expenses 2011-2024 | XXII

22nd Century research and development expenses from 2011 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
22nd Century Annual Research and Development Expenses
(Millions of US $)
2023 $3
2022 $4
2021 $4
2020 $4
2019 $8
2018 $15
2017 $3
2016 $2
2015 $2
2014 $1
2013 $1
2012 $1
2011 $2
2010 $0
22nd Century Quarterly Research and Development Expenses
(Millions of US $)
2024-06-30 $0
2024-03-31 $0
2023-12-31 $-0
2023-09-30 $2
2023-06-30 $1
2023-03-31 $1
2022-12-31 $-1
2022-09-30 $1
2022-06-30 $2
2022-03-31 $1
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $1
2020-06-30 $1
2020-03-31 $1
2019-12-31 $2
2019-09-30 $2
2019-06-30 $2
2019-03-31 $2
2018-12-31 $4
2018-09-30 $4
2018-06-30 $5
2018-03-31 $3
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $1
2011-09-30 $1
2011-06-30 $1
2011-03-31 $0
2010-12-31
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.005B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $194.276B 19.65
Altria (MO) United States $91.401B 10.74
British American Tobacco (BTI) United Kingdom $78.072B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $25.594B 0.00
Universal (UVV) United States $1.323B 10.36
Turning Point Brands (TPB) United States $0.929B 17.86